-
Abiraterone Acetate in Patient-Derived 3D Models
2026-09-22
A translational framework for using Abiraterone acetate as a CYP17 inhibitor in patient-derived prostate cancer spheroids, with emphasis on androgen biology, assay context, compound handling, and the limits of extrapolating organ-confined models to castration-resistant disease.
-
Estradiol Benzoate: Reliable ERα Assays
2026-09-22
Learn how Estradiol Benzoate, SKU B1941, can improve consistency in estrogen receptor signaling research, hormone receptor binding assays, and cell-based viability or proliferation workflows. This scenario-driven guide covers solubility, stock preparation, controls, interpretation, and product-selection criteria using documented specifications.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-09-21
The reference study developed a dendritic-cell delivery strategy that transported fluorescently labeled amikacin into granulomas in mice infected with Mycobacterium avium. Its main contribution is proof of organism-directed localization without detectable systemic amikacin, while preserving antibacterial activity and avoiding increased MCP-1 or CCR2 inflammatory markers.
-
Omeprazole (A2845): Practical Research Guide
2026-09-21
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, biochemical inhibition assays, and related antiulcer activity study workflows. This dossier-based guidance addresses handling, solubility, assay setup, and quality control; the product is for scientific research only and not for diagnostic or medical use.
-
rTMS Activates Cx3cl1-Cx3cr1 Signaling in AD
2026-09-20
This study identifies a cellular pathway through which repetitive transcranial magnetic stimulation may improve Alzheimer’s disease-related pathology: activation of GABAergic neurons increases Cx3cl1 signaling and promotes Cx3cr1-associated microglial clearance of amyloid-β. Its combination of single-cell transcriptomics, plaque analysis, microglial phenotyping, and cognitive assessment provides a mechanistic framework for evaluating non-invasive neuromodulation in Alzheimer’s disease models.
-
Omeprazole (A2845): Practical Research Guide
2026-09-19
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, assay development, and antiulcer activity studies. This guide covers dossier-based parameters, solution handling, QC, and interpretation boundaries; the material is for research use only and not for diagnostic, therapeutic, or medical applications.
-
Ganetespib (STA-9090) Assay Guide
2026-09-18
A scenario-based guide to using Ganetespib (STA-9090), SKU A4385, in cell viability, proliferation, and cytotoxicity workflows. It connects Hsp90 biology with practical stock preparation, assay controls, dose selection, orthogonal validation, and evidence-based product evaluation.
-
Methoxy-X04 for Amyloid Imaging Workflows
2026-09-18
Methoxy-X04 combines brain permeability with nanomolar amyloid-β fibril binding, enabling rapid plaque, oligomer, and cerebrovascular amyloid readouts in Alzheimer’s disease models. This guide shows how to turn the probe into a reproducible workflow for testing exercise-linked extracellular vesicle mechanisms and microglial plaque clearance.
-
CUDC-907: Practical PI3K/HDAC Assay Guide
2026-09-17
CUDC-907 (SKU A4097) provides a research starting point for coordinated investigation of PI3K/AKT signaling and histone deacetylase activity in cancer cell assays. This dossier-driven guide covers preparation, controls, pathway readouts, and limitations; it is not a diagnostic, therapeutic, or clinical-use protocol.
-
Amyloid Beta-Peptide (1-40) (human): Assay Guide
2026-09-17
This scenario-based guide helps researchers control peptide preparation, solvent effects, aggregation state, and assay interpretation when using Amyloid Beta-Peptide (1-40) (human), SKU A1124. It connects product specifications with current evidence on monomeric Aβ signaling and offers practical criteria for selecting an Alzheimer's disease research peptide.
-
Methoxy-X04 for Amyloid Imaging Workflows
2026-09-16
Methoxy-X04 converts amyloid pathology into a spatially resolved fluorescent readout for plaque, oligomer, and vascular studies. This guide connects practical assay design with the rTMS–microglial clearance findings reported in a 5xFAD model, while separating validated product specifications from workflow recommendations.
-
ALDH2 Activation Delays Pressure-Overload Heart Failure
2026-09-16
The reference study identifies ALDH2 as a regulator of cardiomyocyte proliferation, showing that its activation extends the early postnatal proliferative window and improves outcomes in adult mice exposed to ventricular pressure overload. Its use of Alda-1 links aldehyde metabolism with cardiac regeneration and provides a mechanistic framework for cardiac ischemia research and related cardioprotection studies.
-
Amyloid Beta-Peptide (1-40): Assay Design
2026-09-15
Amyloid Beta-Peptide (1-40) (human) is more than an aggregation reagent: it is a controllable model for linking peptide state to optical, cellular, and mechanistic readouts. This guide uses recent ratiometric fibril-imaging research to show how Aβ40 assay design can improve interpretation and reproducibility.
-
Tetrahydromagnolol: CB2 Assay Workflows
2026-09-15
Build cleaner cannabinoid receptor experiments with Tetrahydromagnolol, a potent peripheral CB2 receptor agonist that also provides a measurable GPR55 antagonism window. This guide connects receptor pharmacology with inflammation, analgesia, and exploratory GPCR–cytoskeleton assays while emphasizing controls, dosing, and interpretation.
-
2,2,2-Trichloroethanol for Reliable Assays
2026-09-14
This scenario-based guide explains where 2,2,2-Trichloroethanol fits in protein analysis, molecular biology research, and translational assay workflows without overstating its role in cell viability testing. It details practical compatibility, handling, interpretation, and vendor-selection considerations for SKU C6823.